As I said in my last post that the last announcement to treat...

As I said in my last post that the last announcement to treat bile duct cancer that showed "interim results from the Phase 1 MAST trial demonstrated positive responses in gastrointestinal cancers, and in particular a Complete Response (CR) in bile tract cancer" may make paradigm shift. In addition we're getting closure to get date from 84 patients all 3 platforms. The SP is hammered so hard any prediction can fail but next data release will be make or break for IMU.

I haven't seen LC so exited and believing in Science, however it is too early to predict anything Let's hope next data release proves the market was wrong on VAXINIA and Azer-Cel.